Rab27A Regulates Transport of Cell Surface Receptors Modulating Multinucleation and Lysosome-Related Organelles in Osteoclasts

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Shimada Sugawara, Megumi ^a   Sakai, Eiko ^a   Okamoto, Kuniaki ^a   Fukuda, Mitsunori ^b   Izumi, Tetsuro ^c   Yoshida, Noriaki ^a   Tsukuba, Takayuki ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN K; COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR RECEPTOR; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCLAST DIFFERENTIATION FACTOR; RAB PROTEIN; RAB27A PROTEIN, MOUSE; TNFSF11 PROTEIN, MOUSE;

ANIMAL; ANTAGONISTS AND INHIBITORS; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL NUCLEUS; CYTOLOGY; DOWN REGULATION; DRUG EFFECTS; GENETICS; LYSOSOME; MACROPHAGE; METABOLISM; MOUSE; OSTEOCLAST; PHOSPHORYLATION; RNA INTERFERENCE; UPREGULATION;

ANIMALS; BONE MARROW CELLS; CATHEPSIN K; CELL DIFFERENTIATION; CELL NUCLEUS; CELLS, CULTURED; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 2; LYSOSOMES; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MICE; OSTEOCLASTS; PHOSPHORYLATION; RAB GTP-BINDING PROTEINS; RANK LIGAND; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; RNA INTERFERENCE; UP-REGULATION;

EID: 84928137749     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09620     Document Type: Article

References (48)

1. Stenmark, H. Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol 10, 513-525, doi:10.1038/nrm2728 (2009).
2. Fukuda, M. Regulation of secretory vesicle traffic by Rab small GTPases. Cell Mol Life Sci 65, 2801-2813, doi:10.1007/s00018-008-8351-4 (2008).
3. Bizario, J. C. et al. Griscelli syndrome: characterization of a new mutation and rescue of T-cytotoxic activity by retroviral transfer of RAB27A gene. J Clin Immunol 24, 397-410, doi:10.1023/B:JOCI.0000029119 (2004).
4. Menasche, G. et al. Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat Genet 25, 173-176, doi:10.1038/76024 (2000).
5. Johnson, J. L., Monfregola, J., Napolitano, G., Kiosses, W. B. & Catz, S. D. Vesicular trafficking through cortical actin during exocytosis is regulated by the Rab27a effector JFC1/Slp1 and the RhoA-GTPase-activating protein Geminteracting protein. Mol Biol Cell 23, 1902-1916, doi:10.1091/mbc.E11-12-1001 (2012).
6. Dell'Angelica, E. C., Mullins, C., Caplan, S. & Bonifacino, J. S. Lysosome-related organelles. FASEB J 14, 1265-1278 (2000).
7. Marks, M. S., Heijnen, H. F. & Raposo, G. Lysosome-related organelles: unusual compartments become mainstream. Curr Opin Cell Biol 25, 495-505, doi:10.1016/j.ceb.2013.04.008 (2013).
8. Raposo, G. & Marks, M. S. The dark side of lysosome-related organelles: specialization of the endocytic pathway for melanosome biogenesis. Traffic 3, 237-248 (2002).
9. Booth, A. E., Seabra, M. C. & Hume, A. N. Rab27a and melanosomes: a model to investigate the membrane targeting of Rabs. Biochem Soc Trans 40, 1383-1388, doi:10.1042/BST20120200 (2012).
10. Haddad, E. K., Wu, X., Hammer, J. A. 3rd. & Henkart, P. A. Defective granule exocytosis in Rab27a-deficient lymphocytes from Ashen mice. J Cell Biol 152, 835-842 (2001).
11. Novak, E. K. et al. The regulation of platelet-dense granules by Rab27a in the ashen mouse, a model of Hermansky-Pudlak and Griscelli syndromes, is granulespecific and dependent on genetic background. Blood 100, 128-135 (2002).
12. Baron, R., Neff, L., Louvard, D. & Courtoy, P. J. Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border. J Cell Biol 101, 2210-2222 (1985).
13. Suda, T. et al. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20, 345-357 (1999).
14. Teitelbaum, S. L. & Ross, F. P. Genetic regulation of osteoclast development and function. Nat Rev Genet 4, 638-649, doi:10.1038/nrg1122 (2003).
15. Suda, T., Takahashi, N. & Martin, T. J. Modulation of osteoclast differentiation. Endocr Rev 13, 66-80 (1992).
16. Vaananen, H. K. & Horton, M. The osteoclast clear zone is a specialized cellextracellular matrix adhesion structure. J Cell Sci 108 (Pt 8), 2729-2732 (1995).
17. Vaananen, H. K., Zhao, H., Mulari, M. & Halleen, J. M. The cell biology of osteoclast function. J Cell Sci 113 (Pt 3), 377-381 (2000).
18. Sobacchi, C., Schulz, A., Coxon, F. P., Villa, A. & Helfrich, M. H. Osteopetrosis: genetics, treatment and new insights into osteoclast function. Nat Rev Endocrinol 9, 522-536, doi:10.1038/nrendo.2013.137 (2013).
19. Lacombe, J., Karsenty, G. & Ferron, M. Regulation of lysosome biogenesis and functions in osteoclasts. Cell Cycle 12, 2744-2752, doi:10.4161/cc.25825 (2013).
20. Saftig, P. et al. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc Natl Acad Sci U S A 95, 13453-13458 (1998).
21. Saftig, P. et al. Functions of cathepsin K in bone resorption. Lessons from cathepsin K deficient mice. Adv Exp Med Biol 477, 293-303, doi:10.1007/0-306-46826-3-32 (2000).
22. Lotinun, S. et al. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. J Clin Invest 123, 666-681, doi:10.1172/jci64840 (2013).
23. Roberts, H. C. et al. Altered collagen in tartrate-resistant acid phosphatase (TRAP)-deficient mice: a role for TRAP in bone collagen metabolism. Calcif Tissue Int 80, 400-410, doi:10.1007/s00223-007-9032-2 (2007).
24. Halleen, J. M. et al. Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase. J Biol Chem 274, 22907-22910 (1999).
25. Watanabe, T. et al. Direct stimulation of osteoclastogenesis by MIP-1alpha: evidence obtained from studies using RAW264 cell clone highly responsive to RANKL. J Endocrinol 180, 193-201 (2004).
26. Wilson, S. M. et al. A mutation in Rab27a causes the vesicle transport defects observed in ashen mice. Proc Natl Acad Sci U S A 97, 7933-7938 doi:10.1073/pnas.140212797 (2000).
27. Szewczyk, K. A., Fuller, K. & Chambers, T. J. Distinctive subdomains in the resorbing surface of osteoclasts. PLoS One 8, e60285, doi:10.1371/journal.pone.0060285 (2013).
28. Xia, W. F. et al. Vps35 loss promotes hyperresorptive osteoclastogenesis and osteoporosis via sustained RANKL signaling. J Cell Biol 200, 821-837, doi:10.1083/jcb.201207154 (2013).
29. Oikawa, T., Kuroda, Y. & Matsuo, K. Regulation of osteoclasts by membrane-derived lipid mediators. Cell Mol Life Sci 70, 3341-3353, doi:10.1007/s00018-012-1238-4 (2013).
30. Jancic, C. et al. Rab27a regulates phagosomal pH and NADPH oxidase recruitment to dendritic cell phagosomes. Nat Cell Biol 9, 367-378, doi:10.1038/ncb1552 (2007).
31. Ejlerskov, P. et al. NADPH oxidase is internalized by clathrin-coated pits and localizes to a Rab27A/B GTPase-regulated secretory compartment in activated macrophages. J Biol Chem 287, 4835-4852, doi:10.1074/jbc.M111.293696 (2012).
32. Yokoyama, K. et al. Rab27a negatively regulates phagocytosis by prolongation of the actin-coating stage around phagosomes. J Biol Chem 286, 5375-5382, doi:10.1074/jbc.M110.171702 (2011).
33. Johnson, J. L. et al. Rab27a and Rab27b regulate neutrophil azurophilic granule exocytosis and NADPH oxidase activity by independent mechanisms. Traffic 11, 533-547, doi:10.1111/j.1600-0854.2009.01029.x (2010).
34. Johnson, J. L., Hong, H., Monfregola, J., Kiosses, W. B. & Catz, S. D. Munc13-4 restricts motility of Rab27a-expressing vesicles to facilitate lipopolysaccharide-induced priming of exocytosis in neutrophils. J Biol Chem 286, 5647-5656, doi:10.1074/jbc.M110.184762 (2011).
35. Kim, J. D. et al. An essential role for Rab27a GTPase in eosinophil exocytosis. J Leukoc Biol 94, 1265-1274, doi:10.1189/jlb.0812431 (2013).
36. Goishi, K., Mizuno, K., Nakanishi, H. & Sasaki, T. Involvement of Rab27 in antigen-induced histamine release from rat basophilic leukemia 2H3 cells. Biochem Biophys Res Commun 324, 294-301, doi:10.1016/j.bbrc.2004.09.050 (2004).
37. Toyomura, T. et al. From lysosomes to the plasma membrane: localization of vacuolar-type H+ -ATPase with the a3 isoform during osteoclast differentiation. J Biol Chem 278, 22023-22030, doi:10.1074/jbc.M302436200 (2003).
38. Zhao, H., Laitala-Leinonen, T., Parikka, V. & Vaananen, H. K. Downregulation of small GTPase Rab7 impairs osteoclast polarization and bone resorption. J Biol Chem 276, 39295-39302, doi:10.1074/jbc.M010999200 (2001).
39. Hirvonen, M. J. et al. Rab13 is upregulated during osteoclast differentiation and associates with small vesicles revealing polarized distribution in resorbing cells. J Histochem Cytochem 60, 537-549, doi:10.1369/0022155412448069 (2012).
40. Charles, J. F. et al. The collection of NFATc1-dependent transcripts in the osteoclast includes numerous genes non-essential to physiologic bone resorption. Bone 51, 902-912, doi:10.1016/j.bone.2012.08.113 (2012).
41. Kariya, Y. et al. Rab27a and Rab27b are involved in stimulation-dependent RANKL release from secretory lysosomes in osteoblastic cells. J Bone Miner Res 26, 689-703, doi:10.1002/jbmr.268 (2011).
42. Hu, J. P. et al. Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-kappaB and Akt pathways. Eur J Pharmacol 580, 70-79, doi:10.1016/j.ejphar.2007.11.013 (2008).
43. Yanagawa, M. et al. Cathepsin E deficiency induces a novel form of lysosomal storage disorder showing the accumulation of lysosomal membrane sialoglycoproteins and the elevation of lysosomal pH in macrophages. J Biol Chem 282, 1851-1862, doi:10.1074/jbc.M604143200 (2007).
44. Kamiya, T. et al. Fluorescence microscopic demonstration of cathepsin K activity as the major lysosomal cysteine proteinase in osteoclasts. J Biochem 123, 752-759 (1998).
45. Kasai, K. et al. Rab27a mediates the tight docking of insulin granules onto the plasma membrane during glucose stimulation. J Clin Invest 115, 388-396, doi:10.1172/JCI22955 (2005).
46. Sakai, E. et al. Suppression of RANKL-dependent heme oxygenase-1 is required for high mobility group box 1 release and osteoclastogenesis. J Cell Biochem 113, 486-498, doi:10.1002/jcb.23372 (2012).
47. Hotokezaka, H. et al. U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells. J Biol Chem 277, 47366-47372, doi:10.1074/jbc.M208284200 (2002).
48. Sakai, E. et al. Fisetin inhibits osteoclastogenesis through prevention of RANKL-induced ROS production by Nrf2-mediated up-regulation of phase II antioxidant enzymes. J Pharmacol Sci 121, 288-298, doi:10.1254/jphs.12243FP (2013).